Cryoport, Inc. ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK pharmteco, a global contract development and manufacturing organization, today announced a ...

Discover Editas Medicine's groundbreaking patent for enzymatically active Cas9 fusion molecules, enhancing gene editing precision with innovative nucleic acid applications.

RNA interference (RNAi) technology has gradually become a cutting-edge technology for treating diseases such as genetic ...

Oracle is adding new user experience (UX) enhancements to its Fusion Cloud Supply Chain & Manufacturing (SCM) offering, the company announced at the CloudWorld 2024 conference. These enhancements ...

Roberto Pili, MD, associate dean for cancer research and integrative oncology at the Jacobs School of Medicine and Biomedical Sciences, is the principal investigator on a new five-year, $1.8 million ...

Incorporating fusion associated small transmembrane (FAST ... This breakthrough not only underscores the potential of our technology to overcome current limitations in gene delivery but also ...

The long road ahead ITER, which is currently being built in Cadarache, France, illustrates the inherent complexity of fusion and the difficulty in delivering large nuclear projects. (Courtesy: ITER ...

Patients carrying this fusion gene have a high relapse rate and a poor prognosis, allo-HSCT may be an option to cure this disease. This patient underwent allo-HSCT, a relapse occurred three months ...

In a nutshell: An unlikely contestant has emerged in the race toward cracking the fusion code, which has seen the biggest labs and richest billionaires pouring billions into various projects ...